NIVEN RALPH — SEC Form 4 filings

SEC reporting owner CIK 1168060. 2 Form 4 filings on record with FilingPulse; latest filed 2024-02-07.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-01-24 to 2024-02-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aerovate Therapeutics, Inc. (AVTE)CHIEF SCIENTIFIC OFFICER21 leg · 4,600 sh · $80,2498

Form 4 filings — NIVEN RALPH

FiledFormIssuerReported transactionsSource
2024-02-074Aerovate Therapeutics, Inc. (AVTE)Option exercise (M): 1,400 @ $1.74 · Option exercise (M): 3,200 @ $2.14 · Sale (S): 4,600 @ $17.45 · Option exercise (M): 900 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 · +2 moreEDGAR
2024-01-244Aerovate Therapeutics, Inc. (AVTE)Grant/award (A): 66,586 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1168060 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →